Active Startup: AUM LifeTech Ltd.

News

Published: 10Oct2019

Business Snapshot
Company produces/distributes proprietary FANA oligonucleotides with unique advantages in industrial scale quantities based on proprietary oligonucleotide production methods.

Target Markets
FANA technology can be used for discovery, translation, and potentially for therapeutic development. Company is working with collaborators for therapeutic development for a wide spectrum of genetic diseases as well as making RNA silencing and regulation available to biomedical researchers across the globe.

Intellectual Property
Issued patents on FANA, issued and filed patents on production methods in multiple jurisdictions (US, EPO, SG, CN, CA).

Founders
Veenu Aishwarya (based on Masad Damha's technologies)